GlaxoSmithKline Pharmaceuticals Overview

  • Year Founded
  • 1924

Year Founded

  • Status
  • Public

  • Employees
  • 3,211

Employees

  • Stock Symbol
  • 500660

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $30.78
  • (As of Friday Closing)

GlaxoSmithKline Pharmaceuticals General Information

Description

GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives majority of its revenue from India.

Contact Information

Formerly Known As
H. J. Foster & Co. Limited
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
BOM
Corporate Office
  • GSK House
  • 252, Dr Annie Besant Road, Worli
  • Mumbai, 400030
  • India
+91 022 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GlaxoSmithKline Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$30.78 $30.66 $16.67 - $33.03 $5.21B 169M 10.1K $0.42

GlaxoSmithKline Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022
EV 3,742,887 3,742,887 2,568,691 3,552,534
Revenue 415,744 415,744 401,801 438,087
EBITDA 99,029 99,029 103,884 104,429
Net Income 71,264 71,264 76,053 227,456
Total Assets 426,486 426,486 405,182 611,022
Total Debt 2,238 2,238 1,893 2,648
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GlaxoSmithKline Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GlaxoSmithKline Pharmaceuticals‘s full profile, request access.

Request a free trial

GlaxoSmithKline Pharmaceuticals Executive Team (5)

Name Title Board Seat Contact Info
Juby Chandy Chief Financial Officer, Finance & Board Member
Bhushan Akshikar Board Member & Managing Director
Ajay Nadkarni Executive & Secretary, Administration
Mehernosh Kapadia Board Member & Executive
Raju Krishnaswamy Board Member & Executive
To view GlaxoSmithKline Pharmaceuticals’s complete executive team members history, request access »

GlaxoSmithKline Pharmaceuticals Board Members (13)

Name Representing Role Since
00000 000 Self Independent Director 000 0000
0000000 00000000 GlaxoSmithKline Pharmaceuticals Board Member & Managing Director 000 0000
0000000000000 0000 Self Board Member 000 0000
0000 000000 GlaxoSmithKline Pharmaceuticals Chief Financial Officer, Finance & Board Member 000 0000
000000000 0000000 GlaxoSmithKline Pharmaceuticals Board Member & Executive 000 0000
You’re viewing 5 of 13 board members. Get the full list »

GlaxoSmithKline Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GlaxoSmithKline Pharmaceuticals Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Immunocore 16-Jul-2015 00000 0000 00000 Drug Discovery
Silarus Therapeutics 22-Sep-2014 Early Stage VC 0000 Drug Discovery
To view GlaxoSmithKline Pharmaceuticals’s complete investments history, request access »

GlaxoSmithKline Pharmaceuticals ESG

Risk Overview

Risk Rating

Updated August, 02, 2023

22.14 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,216

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 921

Rank

00.00

Percentile

Pharmaceuticals

Subindustry

00 of 452

Rank

0.00

Percentile

To view GlaxoSmithKline Pharmaceuticals’s complete esg history, request access »

GlaxoSmithKline Pharmaceuticals Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
Immunocore 16-Jul-2015 00000 00000 00 00000 Completed
  • 11 buyers
Silarus Therapeutics 22-Sep-2014 Early Stage VC 0000 Completed
  • 4 buyers
To view GlaxoSmithKline Pharmaceuticals’s complete exits history, request access »

GlaxoSmithKline Pharmaceuticals FAQs

  • When was GlaxoSmithKline Pharmaceuticals founded?

    GlaxoSmithKline Pharmaceuticals was founded in 1924.

  • Where is GlaxoSmithKline Pharmaceuticals headquartered?

    GlaxoSmithKline Pharmaceuticals is headquartered in Mumbai, India.

  • What is the size of GlaxoSmithKline Pharmaceuticals?

    GlaxoSmithKline Pharmaceuticals has 3,211 total employees.

  • What industry is GlaxoSmithKline Pharmaceuticals in?

    GlaxoSmithKline Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is GlaxoSmithKline Pharmaceuticals a private or public company?

    GlaxoSmithKline Pharmaceuticals is a Public company.

  • What is GlaxoSmithKline Pharmaceuticals’s stock symbol?

    The ticker symbol for GlaxoSmithKline Pharmaceuticals is 500660.

  • What is the current stock price of GlaxoSmithKline Pharmaceuticals?

    As of 12-Jul-2024 the stock price of GlaxoSmithKline Pharmaceuticals is $30.78.

  • What is the current market cap of GlaxoSmithKline Pharmaceuticals?

    The current market capitalization of GlaxoSmithKline Pharmaceuticals is $5.21B.

  • What is GlaxoSmithKline Pharmaceuticals’s current revenue?

    The trailing twelve month revenue for GlaxoSmithKline Pharmaceuticals is $416M.

  • What is GlaxoSmithKline Pharmaceuticals’s annual earnings per share (EPS)?

    GlaxoSmithKline Pharmaceuticals’s EPS for 12 months was $0.42.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »